Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 94

Sort by

Sort Order Select

Journal Articles

Comparison of and Immune Reconstitution and Graft Versus Host Disease in 30mg/Kg Anti-T-Lymphocyte Globuline with 60mg/Kg ATLG As Graft Versus Host Disease Prophylaxis in Matched Unrelated Donor Myeloablative Peripheral Blood Stem Cell Transplantation

Radwan Massoud, Evgeny Klyuchnikov, Nico Gagelmann, Tatjana Zabelina, Wolschke Christine, Francis Ayuketang Ayuk, Ulrike Fritsche-Friedland, Axel R. Zander, Nicolaus Kröger

Blood (2021) 138 (Supplement 1): 3897.

https://doi.org/10.1182/blood-2021-153157

Published: 2021

Journal Articles

Factors Affecting Post-Transplant Relapse of Acute Lymphoblastic Leukemia (ALL) in Children According on the Intensity of Conditioning

Elena Vladimirovna Semenova, PhD, Polina Valerievna Kozhokar, Dr., Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Anastasia S Frolova, Dr, Luibov Tsvetkova, Kirill Alexandrovich Ekushov, Dr., Tatiana A Bykova, MD PhD, Anna A. Osipova, Inna Markova, Sergey N. Bondarenko, Boris I Smirnov, Ildar M Barkhatov, MD PhD, Tatyana L. Gindina, Ivan S. Moiseev, Axel R. Zander, Ludmila S Zubarovskaya, MD PhD professor

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-139466

Published: 2020

Journal Articles

Predictive Model of Response to Blinatumomab Therapy in Children and Adults with Relapsed/Refractory B-ALL

Inna Markova, Sergey N. Bondarenko, Olesia V Paina, PhD, Anna A. Osipova, Bella I Ayubova, Eugene A. Bakin, Anna G. Smirnova, Elena Babenko, Elena Vladimirovna Semenova, PhD, Ivan S. Moiseev, Axel R. Zander, Ludmila S Zubarovskaya, MD PhD professor

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-140242

Published: 2020

Journal Articles

Risk Factors for Overall Survival in Children with High Risk Acute Myeloid Leukemia (HR AML) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity of Conditioning Regimens

Elena Vladimirovna Semenova, PhD, Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Polina Valerievna Kozhokar, Dr., Anastasia S Frolova, Dr, Kirill Alexandrovich Ekushov, Dr., Tatiana A Bykova, MD PhD, Anna A. Osipova, Inna Markova, Sergey N. Bondarenko, Boris I Smirnov, Ildar M Barkhatov, MD PhD, Aleksandr Alyanski, Elena V. Babenko, Ivan S. Moiseev, Axel R. Zander, Ludmila S Zubarovskaya, MD PhD professor

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-137652

Published: 2020

Journal Articles

Profile of Checkpoint Molecules Expression on Bone Marrow Cell Populations in Patients with High-Risk Myelodysplastic Syndrome

Nikolai Yu. Tcvetkov, Elena V. Morozova, Olga S. Epifanovskaya, Elena V. Babenko, Maria V. Barabanshikova, Kirill V. Lepik, Eugene A. Bakin, Julia J. Vlasova, Anna G. Smirnova, Axel R. Zander, Ivan S. Moiseev

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-141997

Published: 2020

Journal Articles

The Outcome of Patients with Advanced Phase Chronic Myeloid Leukemia with and without Allogeneic Hemopoietic Stem Cell Transplantation

Elena V. Morozova, Julia J. Vlasova, Maria V. Barabanshikova, Axel R. Zander, Ksenia Jurovskaya, Tatyana L. Gindina, Ildar Barhatov, Sergey N. Bondarenko, Ivan S. Moiseev, Ludmila S Zubarovskaya, MD PhD professor, Aleksandr D. Kulagin, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-139452

Published: 2020

Journal Articles

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Blood (2017) 130 (Supplement 1): 2604.

https://doi.org/10.1182/blood.V130.Suppl_1.2604.2604

Published: 2017

Journal Articles

Regaining the Tumor Control in Relapsed/Refractory Hodgkin Lymphoma after Nivolumab Failure with Addition of Another Antineoplastic Agent

Nataliia Mikhailova, Kirill Lepik, Elena Kondakova, Evgeniya Borzenkova, Yuri Zalaylov, Andrey Kozlov, Vadim Baykov, Lilia Stelmakh, Luibov Tsvetkova, Olesya Smykova, Axel R Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor

Blood (2017) 130 (Supplement 1): 1521.

https://doi.org/10.1182/blood.V130.Suppl_1.1521.1521

Published: 2017

Journal Articles

Hematopoietic Stem Cell Transplantation for Children with Neurological Diseases Improves the Outcomes and Not Leads to Significant Late Effects — Report from Russian Group

Kirill Kirgizov, MD PhD, Anastasia Borovkova, MD, Elena Skorobogatova, MD PhD, Tatjana Bykova, MD PhD, Alexey A Maschan, MD PhD Professor, Ludmila S Zubarovskaya, MD PhD Professor, Axel R. Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor, Alexander Rumyantsev, MD PhD Professor

Blood (2017) 130 (Supplement 1): 4526.

https://doi.org/10.1182/blood.V130.Suppl_1.4526.4526

Published: 2017

Journal Articles

Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

Elena V Morozova, MDPhD, Ivan S Moiseev, MD PhD, Maria V Barabanshikova, MDPhD, Elena I Darskaya, MDPhD, Sergey N. Bondarenko, PhDMD, Ludmila S Zubarovskaya, MD PhD Professor, Vadim Baykov, Alexandr L Alyanski, Ildar M Barkhatov, MD PhD, Axel R. Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor

Blood (2017) 130 (Supplement 1): 4492.

https://doi.org/10.1182/blood.V130.Suppl_1.4492.4492

Published: 2017

Journal Articles

Impact of Minimal Residual Disease after Allografting Detected By JAK2V617F, MPL or Calreticulin in Myelofibrosis Patients

Nicolaus Kroeger, Anita Badbaran, Tatjana Zabelina, MD, Maximilian Christopeit, MD, Christine Wolschke, MD, Francis Ayuk, MD, Axel R. Zander, Professor, Haefaa Alchalby, MD, Ulrike Bacher, Ioanna N Triviai, PhD, Boris Fehse, PhD

Blood (2015) 126 (23): 4343.

https://doi.org/10.1182/blood.V126.23.4343.4343

Published: 2015

Journal Articles

Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA

Christian T. Dietz, PhD, Alice Charlotte Fabarius, PhD, Michael Lauseker, PhD, Susanne Saussele, Lida Kalmanti, Sébastien Rinaldetti, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martine Jotterand, Alois Gratwohl, Axel R. Zander, Professor, Nicolaus Kröger, Dietrich W. Beelen, MD, Jürgen Novotny, Christoph Nerl, Christof Scheid, MD PhD, Karsten Spiekermann, Jiri Mayer, MD, Herbert G. Sayer, Christiane Falge, Donald Bunjes, MD, Hartmut Döhner, Prof. Dr., Arnold Ganser, Peter Brossart, MD, Rainer Schwerdtfeger, Herrad Baumann, Rolf Kuse, Hans Walter Lindemann, MD, Matthias Bormann, Bernd Hertenstein, MD, Gabriela M. Baerlocher, Carlo Aul, MD, Peter Staib, Matthias Edinger, MD, Michael Schatz, Axel A Fauser, Renate Arnold, MD, Dieter K. Hossfeld, MD, Hans-Jochem Kolb, Susanne Schnittger, PhD, Martin C. Müller, MD, Andreas Reiter, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Joerg Hasford, Michele Baccarani, Ruediger Hehlmann, MD

Blood (2015) 126 (23): 1581.

https://doi.org/10.1182/blood.V126.23.1581.1581

Published: 2015

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Imatinib-Era: Update on the Survival Outcome Following Allogeneic HSCT after Imatinib Failure; Results of the German CML Study IV

Blood (2014) 124 (21): 2567.

https://doi.org/10.1182/blood.V124.21.2567.2567

Published: 2014

Journal Articles

Allogeneic Stem Cell Transplantation for CML in Accelerate or Blastic Phase

Elena V Morozova, MD PhD, Tatjana Zabelina, MD, Francis Ayuk, MD, Christine Wolschke, MD, Thomas Stübig, MD, Sergey N Bondarenko, Alexandr L. Alianskii, MD, Axel R. Zander, MD, Boris Afanasyev, MD, Nicolaus Kröger, MD

Blood (2014) 124 (21): 1220.

https://doi.org/10.1182/blood.V124.21.1220.1220

Published: 2014

Journal Articles

Quality Of Life After Allogeneic Stem Cell Transplantation In Patients With Myelofibrosis (CMWP of EBMT)

Nora Machate, Haefaa Alchalby, MD, Susanne Sehner, Tatjana Zabelina, MD, Daniel Wolff, MD, Guido Kobbe, MD, Martin Bornhäuser, MD, Herrad Baurmann, MD, Wolfgang A Bethge, MD, Gerald Wulf, MD, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2013) 122 (21): 2974.

https://doi.org/10.1182/blood.V122.21.2974.2974

Published: 2013

Journal Articles

Effective Prevention of Acute and Chronic Graft-Versus-Host Disease with Anti-Lymphocyte Globulin (ATG) without Increase of Relapse in HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation.

Nicolaus Kröger, Tatjana Zabelina, Francis Ayuk, Haefaa Alchalby, MD, Christine Wolschke, Thomas Stübig, Evgeny Klyuchnikov, Jürgen Berger, Axel R. Zander, MD

Blood (2012) 120 (21): 3055.

https://doi.org/10.1182/blood.V120.21.3055.3055

Published: 2012

Journal Articles

Extracorporeal Photopheresis (ECP) As Part of Combined Effective Immunotherapy Treatment of Graft-Versus-Host Disease

Tatyana Bykova, Dr., Andrey Kozlov, Dr., Maria Estrina, Dr., Natalia V Stancheva, Elena V Semenova, Ludmila S Zubarovskaya, prof., Boris V Afanasyev, prof., Axel R. Zander, MD

Blood (2012) 120 (21): 1953.

https://doi.org/10.1182/blood.V120.21.1953.1953

Published: 2012

Journal Articles

Randomized Trial On GvHD Prophylaxis with or without Anti T Cell Globulin ATG Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Updated Results and Evaluation of the European Group for Blood and Marrow Transplantation (EBMT) Risk Score.

Juergen Finke, Claudia Schmoor, PhD, Wolfgang A. Bethge, MD, Hellmut Ottinger, MD, Matthias Stelljes, MD, Axel R. Zander, MD, Liisa Volin, Dominik Heim, MD, Rainer Schwerdtfeger, Hartmut Bertz, Olga Grishina, MD, Gerard Socie

Blood (2012) 120 (21): 3090.

https://doi.org/10.1182/blood.V120.21.3090.3090

Published: 2012

Journal Articles

Achievement of Sustained Molecular Remission Induces Long-Term Freedom From Disease After Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

Nicolaus Kröger, Tatjana Zabelina, MD, Francis Ayuk, MD, Christine Wolschke, MD, Haefaa Alchalby, Anita Badbaran, Djordje Atanackovic, M.D., Georgia Schilling, MD, Orhan Sezer, MD, PhD, Ulrike Bacher, MD, Thomas Stübig, MD, Boris Fehse, Ph.D., Axel R. Zander, MD

Blood (2011) 118 (21): 148.

https://doi.org/10.1182/blood.V118.21.148.148

Published: 2011

Journal Articles

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

Blood (2011) 118 (21): 1019.

https://doi.org/10.1182/blood.V118.21.1019.1019

Published: 2011

NARROW

Comparison of and Immune Reconstitution and Graft Versus Host Disease in 30mg/Kg Anti-T-Lymphocyte Globuline with 60mg/Kg ATLG As Graft Versus Host Disease Prophylaxis in Matched Unrelated Donor Myeloablative Peripheral Blood Stem Cell Transplantation

Factors Affecting Post-Transplant Relapse of Acute Lymphoblastic Leukemia (ALL) in Children According on the Intensity of Conditioning

Predictive Model of Response to Blinatumomab Therapy in Children and Adults with Relapsed/Refractory B-ALL

Risk Factors for Overall Survival in Children with High Risk Acute Myeloid Leukemia (HR AML) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity of Conditioning Regimens

Profile of Checkpoint Molecules Expression on Bone Marrow Cell Populations in Patients with High-Risk Myelodysplastic Syndrome

The Outcome of Patients with Advanced Phase Chronic Myeloid Leukemia with and without Allogeneic Hemopoietic Stem Cell Transplantation

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Regaining the Tumor Control in Relapsed/Refractory Hodgkin Lymphoma after Nivolumab Failure with Addition of Another Antineoplastic Agent

Hematopoietic Stem Cell Transplantation for Children with Neurological Diseases Improves the Outcomes and Not Leads to Significant Late Effects — Report from Russian Group

Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

Impact of Minimal Residual Disease after Allografting Detected By JAK2V617F, MPL or Calreticulin in Myelofibrosis Patients

Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Imatinib-Era: Update on the Survival Outcome Following Allogeneic HSCT after Imatinib Failure; Results of the German CML Study IV

Allogeneic Stem Cell Transplantation for CML in Accelerate or Blastic Phase

Quality Of Life After Allogeneic Stem Cell Transplantation In Patients With Myelofibrosis (CMWP of EBMT)

Effective Prevention of Acute and Chronic Graft-Versus-Host Disease with Anti-Lymphocyte Globulin (ATG) without Increase of Relapse in HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation.

Extracorporeal Photopheresis (ECP) As Part of Combined Effective Immunotherapy Treatment of Graft-Versus-Host Disease

Randomized Trial On GvHD Prophylaxis with or without Anti T Cell Globulin ATG Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Updated Results and Evaluation of the European Group for Blood and Marrow Transplantation (EBMT) Risk Score.

Achievement of Sustained Molecular Remission Induces Long-Term Freedom From Disease After Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only